Bisphosphonate complexation and calcium doping in silica xerogels as a combined strategy for local and controlled release of active platinum antitumor compounds
- PMID: 17637988
- DOI: 10.1039/b705239a
Bisphosphonate complexation and calcium doping in silica xerogels as a combined strategy for local and controlled release of active platinum antitumor compounds
Abstract
The production of bone substitute biomimetic materials which could also act as antitumoral drug release agents is of enormous interest. We report in this paper the synthesis and characterization of a novel platinum dinuclear complex containing a geminal bisphosphonate and its embodiment into xerogels prepared by the sol-gel method. Our goal was to obtain a hybrid inorganic matrix that could release a platinum species active against bone tumors or metastases, upon local implant. Two silica xerogels were considered: one was composed of pure silica, while the other contained also some calcium as potential release-modulating agent thanks to its high affinity for bisphophonates. The platinum-complex loading capacity of the inorganic matrices, the release kinetics in buffer simulating physiological conditions, and the stability upon storage were investigated as a function of Pt-complex concentration and calcium addition. We found that the presence of calcium in the composites deeply influences not only the stability of the formulations but also the nature of the platinum complex liberated in solution.
Similar articles
-
Silica xerogels and hydroxyapatite nanocrystals for the local delivery of platinum-bisphosphonate complexes in the treatment of bone tumors: a mini-review.J Inorg Biochem. 2012 Dec;117:237-47. doi: 10.1016/j.jinorgbio.2012.06.004. Epub 2012 Jun 15. J Inorg Biochem. 2012. PMID: 22824154 Review.
-
A new dinuclear platinum complex with a nitrogen-containing geminal bisphosphonate as potential anticancer compound specifically targeted to bone tissues.J Inorg Biochem. 2008 Dec;102(12):2078-86. doi: 10.1016/j.jinorgbio.2008.07.008. Epub 2008 Jul 26. J Inorg Biochem. 2008. PMID: 18760482
-
Synthesis, characterization, and cytotoxicity of dinuclear platinum-bisphosphonate complexes to be used as prodrugs in the local treatment of bone tumours.Dalton Trans. 2009 Dec 28;(48):10904-13. doi: 10.1039/b919721d. Epub 2009 Nov 16. Dalton Trans. 2009. PMID: 20023921
-
In vivo tissue response to resorbable silica xerogels as controlled-release materials.Biomaterials. 2005 Mar;26(9):1043-52. doi: 10.1016/j.biomaterials.2004.04.004. Biomaterials. 2005. PMID: 15369693
-
Silica xerogels as pharmaceutical drug carriers.Expert Opin Drug Deliv. 2009 May;6(5):485-98. doi: 10.1517/17425240902902307. Expert Opin Drug Deliv. 2009. PMID: 19413456 Review.
Cited by
-
Synthesis and biological evaluation of novel platinum complexes of imidazolyl-containing bisphosphonates as potential anticancer agents.J Biol Inorg Chem. 2015 Dec;20(8):1263-75. doi: 10.1007/s00775-015-1305-z. Epub 2015 Nov 3. J Biol Inorg Chem. 2015. PMID: 26531104
-
Preparation and Biological Evaluation of Two Novel Platinum(II) Complexes Based on the Ligands of Dipicolyamine Bisphosphonate Esters.Molecules. 2016 Feb 24;21(3):255. doi: 10.3390/molecules21030255. Molecules. 2016. PMID: 26927037 Free PMC article.
-
Poly[tri-μ-aqua-di-aqua-μ-phosphono-formato-cobalt(II)sodium].Acta Crystallogr Sect E Struct Rep Online. 2013 May 18;69(Pt 6):i35. doi: 10.1107/S1600536813012853. Print 2013 Jun 1. Acta Crystallogr Sect E Struct Rep Online. 2013. PMID: 23794966 Free PMC article.
-
Bone tumor-targeted delivery of theranostic 195mPt-bisphosphonate complexes promotes killing of metastatic tumor cells.Mater Today Bio. 2020 Dec 7;9:100088. doi: 10.1016/j.mtbio.2020.100088. eCollection 2021 Jan. Mater Today Bio. 2020. PMID: 33490949 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical